药物性红皮病  

Drug-Induced Erythroderma

作　　者：陈佳[1] 曾学思[1] 

机构地区：[1]中国医学科学院,中国协和医科大学皮肤病研究所,南京210042

出　　处：《国际皮肤性病学杂志》2006年第1期10-12,共3页International Journal of Dermatology and Venereology

摘　　要：随着药物的使用和新药的开发应用,药物过敏引起的红皮病呈上升趋势,致敏药也逐渐增多。螺内酯、可待因等可引起药物超敏反应综合征、氨苯砜和万古霉素等分别可引起氨苯砜综合征及红人综合征。红皮病可为这些综合征的皮肤表现,也可单独出现。药物性红皮病应与其他原因所致红皮病相鉴别。Along with the development and applieation of new drags, the incidence of drag-induced erythroderma tends to increase, so does the number of sensitizing drugs. Spironolactone and codeine ean cause drug hypersensitivity syndrome, while dapsone and vaneomycin can cause dapsone syndrnme and red-man syndrome re speetively. Erylhroderma can be the skin manifestation of these syndromes, or occurs alone. It is important to differentiate erythroderma induced by drugs from that by other causes.

关 键 词：皮炎 剥脱性 药物毒性 

分 类 号：R758.2[医药卫生—皮肤病学与性病学]